HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Luis Anibarro Selected Research
Luis Anibarro Research Topics
Disease
8
Tuberculosis (Tuberculoses)
12/2021 - 07/2011
8
Infections
12/2021 - 05/2010
3
Latent Tuberculosis
01/2020 - 09/2011
2
Inflammation (Inflammations)
01/2020 - 01/2019
2
Meningitis
05/2010 - 05/2010
2
Silicosis
05/2010 - 05/2010
1
Latent Infection
01/2020
1
Pulmonary Tuberculosis
01/2019
1
Erythema Induratum (Bazin Disease)
11/2015
1
Erythema
08/2012
1
Chronic Kidney Failure (Chronic Renal Failure)
08/2012
1
Alcoholism (Alcohol Abuse)
01/2004
Drug/Important Bio-Agent (IBA)
8
Interferon-gamma (Interferon, gamma)
IBA
12/2021 - 05/2010
8
Tuberculin (PPD)
IBA
01/2018 - 05/2010
4
Interferons
IBA
01/2018 - 07/2011
3
Gold
IBA
12/2021 - 08/2012
2
Proteins (Proteins, Gene)
FDA Link
01/2020 - 01/2019
2
Biomarkers (Surrogate Marker)
IBA
01/2020 - 01/2019
2
Pyrazinamide
FDA Link
Generic
05/2010 - 05/2010
2
Ethambutol (Myambutol)
FDA Link
Generic
05/2010 - 05/2010
2
Isoniazid (Ftivazide)
FDA Link
Generic
05/2010 - 05/2010
2
Rifampin (Rifampicin)
FDA Link
Generic
05/2010 - 05/2010
1
Antigens
IBA
12/2021
1
Iron
IBA
01/2020
1
Lipids
IBA
01/2020
1
RNA (Ribonucleic Acid)
IBA
01/2020
1
Transferrin (beta 2 Transferrin)
IBA
01/2020
1
Apoprotein(a) (Apolipoprotein (a))
IBA
01/2020
1
Carbohydrates
IBA
01/2019
1
Indicators and Reagents (Reagents)
IBA
08/2012
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2011
1
Pharmaceutical Preparations
IBA
01/2004
Therapy/Procedure
3
Therapeutics
01/2018 - 09/2011